Lichen China
LICN
7 hedge funds and large institutions have $341K invested in Lichen China in 2024 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 3 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
17% more funds holding
Funds holding: 6 → 7 (+1)
5.85% more ownership
Funds ownership: 0.86% → 6.71% (+5.8%)
23% less capital invested
Capital invested by funds: $445K → $341K (-$104K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$1.85M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$543K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$319K |
| 4 |
Two Sigma Investments
New York
|
+$25.3K |
| 5 |
JF
Jump Financial
Chicago,
Illinois
|
+$15.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MG
Marex Group
London,
|
-$224K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$87.4K |
| 3 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$22.1K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$4.43K |
LICN Hedge Fund Activity: Q4 2024 in Review
7 of the 7,607 institutional investors tracked by Wall St. Rank reported a position in Lichen China (LICN) for Q4 2024, worth a combined $341K — down 23% from $445K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new LICN positions and 3 closed out — a net gain of 1 holder — while 2 added to existing stakes and 1 trimmed.
The largest buyer was Sabby Management, opening a new position worth an estimated $1.85M. The largest seller was Marex Group, exiting entirely with an estimated $224K sold.
- 7 institutional investors held Lichen China (LICN) as of Q4 2024, up from 6 in Q3 2024.
- Funds reported $341K of Lichen China stock for Q4 2024, down 23% quarter-over-quarter.
- 4 funds opened new Lichen China positions in Q4 2024 and 3 closed out, a net change of +1 holder.
- The largest Lichen China buyer in Q4 2024 was Sabby Management, an estimated $1.85M added.
- The largest Lichen China seller in Q4 2024 was Marex Group, an estimated $224K sold.
Based on aggregated 13F filings for Q4 2024.